drugset / Trial / NCT05126316

A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen

NCT05126316

Phase 1 Completed 30 enrolled H. Lundbeck A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main goal of this trial is to learn more about the safety of repeated dosing with Lu AG09222. The trial doctors will keep track of the participant's overall health by asking them how they are and by analyzing blood and urine samples.

Timeline

Start
2021-11-01
Primary completion
2022-07-12
Completion
2022-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG09222 Monoclonal antibody

Indications